Subscribe

NVCR
NovoCure Announces Positive Phase 3 Trial Results
2024-12-02
FOOD CHAINS
Kroger Extends Exchange Offers and Consents, Shares Down 2.2%
2024-12-02
RC
Ready Capital (RC) to Acquire United Development Funding IV (UDF IV)
2024-12-02
UNITED STATES
PHARMACEUTICAL
HEALTH CARE
PTCT
PTC Therapeutics Strikes $1B Deal with Novartis
PTC Therapeutics, Inc. has just announced a significant exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corporation for its PTC518 Huntington's disease program. As part of this deal, PTC will receive an upfront payment of $1.0 billion and is eligible to receive up to $1.9 billion in development, regulatory, and sales milestones. Additionally, PTC will share profits in the U.S. and receive double-digit tiered royalties on ex-U.S. net sales. The PTC518...
Monday, December 02
Market Inference Newsletter
TOP STORIES
Aquestive Therapeutics Nears FDA Submission
Aquestive Therapeutics, Inc. (NASDAQ: AQST) has announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding its planned...
ASP Isotopes Hosts Investor Event in South Africa
ASP Isotopes Inc. has announced the hosting of an investor access event in South Africa from January 14-16, 2025. The event is open to all...
Super Micro Computer Clears Management of Misconduct
Super Micro Computer, Inc. (NASDAQ: SMCI) has announced the completion of a review by an independent special committee formed by the company's...
Applied Digital Secures $150M Financing from Macquarie Group
Applied Digital Corporation (NASDAQ: APLD) has closed a $150 million senior secured debt financing with Macquarie Equipment Capital, Inc., a...

Market Trends

CONSUMER DISCRETIONARY
UNITED STATES
BUSINESS SERVICES
Bread Financial (BFH) Increases Share Repurchase Program
Bread Financial® Holdings, Inc. (NYSE: BFH) has announced a significant increase in its 2024 share repurchase program. The board of directors has...
Monday, December 02
Key Insights into PG&E – A Must-Read for Investors
PCG
Don't Buy Cloudflare Before Checking Its Fundamentals!
UNITED STATES
Key Factors to Consider Before Buying RVMD's Downturn
HEALTH CARE
A Short Intro for Iron Mountain Investors
REAL ESTATE
Navigating Li Auto – Understanding the Fundamental Basics
CHINA
Why Are People Talking About Investing in CUK?
CONSUMER DISCRETIONARY
Insights on Investing in KDP from Our Analysts
CONSUMER STAPLES
HEALTH CARE
PHARMACEUTICAL
UNITED STATES
Pfizer Stock Defies Yearly Trends, Soars Today
Pfizer stock is trading -19.75% below its average target price of $32.66 after marking a 1.5%...
Sunday, December 01
Exploring Freeport-McMoRan – A Stock Overview
INDUSTRIAL METALS & MINING
Energy Transfer LP Rises 2.3% – Potential for Further Growth?
UTILITIES
Buying Merck & (MRK)? Here's What You Must Know.
MRK
Considering an Investment in PDD? Here's What You Need to Know
BUSINESS SERVICES
Unpacking the Momentum Behind Aegon Stock
FINANCE
Key Insights for Summit Therapeutics Shareholders
SMMT
The Critical Facts About Exelixis Today
HEALTH CARE
Popular
Do Analysts Recommend MRVL at $92.69?
Why Is WDAY Falling Today?
What Do You Need to Know About Kraft Heinz (KHC) Before Investing?
Unveiling the Momentum Driving BHP Shares
Analyzing Credicorp (BAP) – Is There Room for Further Growth Despite Overvaluation?
Here Are Some Essential Facts About Stellantis
Cameco Stock – Key Facts Every Investor Should Know
Preminium Access

In Focus

Saturday, November 30
Unlocking the Potential of Estée Lauder – Insights from Our Analysts
Saturday, November 30
Analyzing Equity Residential (EQR) Stock Performance
Saturday, November 30
Rocket Lab Wins $23.9M Award
Saturday, November 30
Triumph Financial Declares Increased Dividend
Saturday, November 30
Walgreens Boots Alliance shares drop 0.4%
Saturday, November 30
Key Factors to Consider Before Selling MFG After Today's Rally
Saturday, November 30
Understanding Comcast Stock – Essential Fundamentals Before Investing
Saturday, November 30
Assessing the Validity of Bearish Ratings on Tesla (TSLA)